Shanghai Yangpu District Central Hospital is a Chinese private company located in Shanghai. The firm provides general medical and surgical hospital services.

Prison (Shandong) Biomedical Technology Co., Ltd., established on 2020-07-30, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. Its products include toripalimab injection, UBP1211, JS002, and UBP1213. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China.

Huai'an Yitai Biotechnology Co., Ltd., established on 2018-07-11, Business scope includes biotechnology,genetic testing technology,Medical technology research and development,transfer,Consulting and Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Pumu (Beijing) Biotechnology Co., Ltd., established on 2020-06-09, Business scope includes biotechnology,Basic Medicine,Pharmacy,clinical medicine,Small Molecule Drug Synthesis,Small Molecule Preparations,Technical development of clinical biomarkers,technical consulting,technology transfer,Technology Exchange,Technology Promotion,Technical Services;Medical Research and Experimental Development;Natural science research and experimental development;Import and export,Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Huzhou Arthur Pharmaceutical Co., Ltd., established on 2021-09-14, Business scope includes licensed projects:pharmaceutical production;Health food production;Drug Wholesale;Drug import and export;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Health Supplies(non food)Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It is also advancing rintodestrant, a potential oral selective estrogen receptor degrader, or serd, for the treatment of er+ breast cancer. It is committed to improving the lives of those impacted by cancer. It is also executing a tumor-agnostic development program, with late-stage clinical trials ongoing in multiple tumor types.

Cytori develops medical devices. They also develop and provide therapeutic options and autologous cell therapies. They provide research and development services for the healthcare sector.

Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.

Part of Genetron Holdings Ltd., Genetron Health (Beijing) Co., Ltd. is a company headquartered in China. The firm manufactures health management products for cancer clinical treatment.

Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. It was founded in 2009 and headquartered in Seattle, Washington.

Chongqing Sino Bio-pharmaceutical Co., Ltd. develops and sells drugs and medical devices. The firm manufactures medical devices for the treatment of hepatitis and support of liver transplantation. The company was founded on June 1, 1995 and is headquartered in Chongqing, China

Chengdu Jinrui Foundation Biotechnology Co., Ltd., established on 2009-05-12, Business scope includes licensed projects:Drug import and export;Drug Wholesale;Drug retail;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Socioeconomic Advisory Services;Technology Import and Export;Biochemical product technology research and development;Domestic trade agent;Health Consulting Services(Does not include medical services);business management;Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).